Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2026)
Alterity Therapeutics (ATHE) posted Prepaid Assets of $575839.5 for Q2 2026, up 12.44% on a QoQ basis from $512117.8 in Q4 2025, and down 89.75% year-over-year from $5.6 million in Q2 2025.
Analysis
Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2026) Analysis & Trends
Alterity Therapeutics has reported Prepaid Assets for 18 years, with the latest figure at $575839.5 in Q2 2026.
- On a quarterly basis, Prepaid Assets fell 89.75% year-over-year to $575839.5 in Q2 2026; TTM through Jun 2026 was $575839.5, a 89.75% decrease from a year earlier, with the FY2026 full-year figure at $575839.5, down 89.75% from the prior year.
- Prepaid Assets was $575839.5 for Q2 2026 at Alterity Therapeutics, up from $512117.8 in the prior quarter.
- The five-year high for Prepaid Assets was $5.6 million in Q2 2025, with the low at $23563.0 in Q2 2024.
- Average Prepaid Assets over 5 years is $1.2 million, with a median of $520809.4 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 97.74% in 2023, then jumped 23749.94% in 2025.
- Over 5 years, Prepaid Assets stood at $520809.4 in 2022, then soared by 361.03% to $2.4 million in 2023, then slumped by 94.27% to $137668.3 in 2024, then soared by 271.99% to $512117.8 in 2025, then grew by 12.44% to $575839.5 in 2026.
- The last three Prepaid Assets figures came in at $575839.5 (Q2 2026), $512117.8 (Q4 2025), and $5.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Alterity Therapeutics | 72.80 Mn | 72.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 575,839.54 |
| Dec 31, 2025 | 512,117.76 |
| Jun 30, 2025 | 5.62 Mn |
| Dec 31, 2024 | 137,668.33 |
| Jun 30, 2024 | 23,563.00 |
| Dec 31, 2023 | 2.40 Mn |
| Jun 30, 2023 | 26,092.86 |
| Dec 31, 2022 | 520,809.36 |
| Jun 30, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Jun 30, 2021 | 843,790.23 |
| Dec 31, 2020 | 254,870.38 |
| Jun 30, 2020 | 378,922.26 |
| Dec 31, 2019 | 211,606.15 |
| Jun 30, 2019 | 442,536.67 |
| Dec 31, 2018 | 80.85 Bn |
| Jun 30, 2018 | 201.84 Bn |
| Dec 31, 2017 | 300,146.52 |
| Jun 30, 2017 | 247.60 Bn |
| Dec 31, 2016 | 107,128.62 |